Lazard Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,812
| Closed | -$21K | – | 2561 |
|
|
2025
Q1 | $21K | Buy |
+4,812
| New | +$21K | ﹤0.01% | 2111 |
|
|
2024
Q4 | – | Sell |
-4,218
| Closed | -$55K | – | 2571 |
|
|
2024
Q3 | $55K | Buy |
+4,218
| New | +$55K | ﹤0.01% | 1905 |
|
|
2023
Q4 | – | Sell |
-12,384
| Closed | -$67K | – | 2520 |
|
|
2023
Q3 | $67K | Buy |
+12,384
| New | +$67K | ﹤0.01% | 1774 |
|
|
2022
Q3 | – | Sell |
-5,655
| Closed | -$85K | – | 2600 |
|
|
2022
Q2 | $85K | Buy |
+5,655
| New | +$85K | ﹤0.01% | 1576 |
|
|
2021
Q4 | – | Sell |
-1,801
| Closed | -$51K | – | 2487 |
|
|
2021
Q3 | $51K | Buy |
+1,801
| New | +$51K | ﹤0.01% | 1681 |
|
|
2021
Q2 | – | Sell |
-1,524
| Closed | -$46K | – | 2096 |
|
|
2021
Q1 | $46K | Buy |
+1,524
| New | +$46K | ﹤0.01% | 1474 |
|